0001562180-20-004289.txt : 20200604 0001562180-20-004289.hdr.sgml : 20200604 20200604174417 ACCESSION NUMBER: 0001562180-20-004289 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200602 FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson David CENTRAL INDEX KEY: 0001578696 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 20943907 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-06-02 false 0001293971 bluebird bio, Inc. BLUE 0001578696 Davidson David C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 false true false false Chief Medical Officer Common Stock 2020-06-02 4 S false 10.00 63.3626 D 39924.00 D Common Stock 2020-06-02 4 S false 32.00 64.2432 D 39892.00 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. The range in prices for the transaction reported on this line was $62.76 to $63.57. The average weighted price was $63.3626. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $63.76 to $64.30. The average weighted price was $64.2432. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Helen C. Fu, Attorney-in-Fact 2020-06-04